Robin Andrulevich
Personalreferent bei SANA BIOTECHNOLOGY, INC.
Aktive Positionen von Robin Andrulevich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Personalreferent | 01.09.2018 | - |
| Washington Biotechnology & Biomedical Association | Direktor/Vorstandsmitglied | 01.12.2017 | - |
Karriereverlauf von Robin Andrulevich
Ehemalige bekannte Positionen von Robin Andrulevich
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| JUNO THERAPEUTICS INC | Personalreferent | 01.10.2014 | 01.04.2018 |
Acepodia Biotechnologies, Ltd.
 Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Direktor/Vorstandsmitglied | 03.11.2021 | - |
| AMAZON.COM, INC. | Corporate Officer/Principal | - | - |
Ausbildung von Robin Andrulevich
| University of Connecticut | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 6 |
| Taiwan | 2 |
Operativ
| Human Resources Officer | 2 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMAZON.COM, INC. | Retail Trade |
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
| Washington Biotechnology & Biomedical Association | |
Acepodia Biotechnologies, Ltd.
Acepodia Biotechnologies, Ltd. BiotechnologyHealth Technology Acepodia Biotechnologies, Ltd. engages in the development of cell therapies to treat patients with cancers. Its business information includes biotechnology service industry, intellectual property rights, and wholesale and retail trade of chemical raw materials. The company was founded by Patrick Yang, and by Sonny Hsiao on June 19, 2017 and is headquartered in Taipei, Taiwan. | Health Technology |
- Börse
- Insiders
- Robin Andrulevich
- Erfahrung